Streetbeat News

Partnerships

ME

23andMe and Nightingale Health have announced a strategic collaboration to pilot Nightingale Health's Blood Metabolomics Panel with a cohort of 23andMe members. Up to 5,000 23andMe+ Premium and Total Health members will receive free blood testing through Nightingale's Remote Health Check. The pilot aims to evaluate customer feedback on blood testing, at-home sample collection, and the utility of the data when combined with 23andMe's genetic products.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:33 am

C

Citigroup's Citi Securities Services has secured a mandate from asset manager Nuveen to manage 23 new ETFs worth approximately $9 billion, expanding Citi's ETF services business.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:18 am

ESPR

Esperion has entered into a royalty purchase deal with Omers Life Sciences, receiving $304.7 million in exchange for 100% interest in its royalty entitlement on Daiichi Sankyo Europe's net sales of Bempedoic Acid products in Europe.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:06 am

ASNS

Actelis Networks shares are trading higher following the announcement of a $300,000 order from a new channel partner in Italy for a national transportation infrastructure project.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:01 am

CARM

Carisma Therapeutics shares are trading higher after the company announced the nomination of the first in vivo CAR-M development candidate for hepatocellular carcinoma under collaboration with Moderna.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:00 am

COSM

Cosmos Health shares are trading higher after the company signed an exclusive distribution agreement with Pharmalink for its Sky Premium Life products in the UAE, with an initial purchase order for 130,000 units.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:00 am

AAPL

INTC

Rain AI, a startup backed by Sam Altman, has appointed former Apple chip executive Jean-Didier Allegrucci to lead its hardware engineering. This move is part of Rain AI's efforts to develop innovative, energy-efficient AI semiconductors. The company is exploring in-memory compute technology to enhance AI models.

Portfolio Pulse from Benzinga Neuro

June 28, 2024 | 9:54 am

BIIB

Eisai and Biogen have launched their Alzheimer's drug LEQEMBI in China. The drug, which targets amyloid-beta aggregates, is the first approved treatment to reduce disease progression and cognitive decline. Eisai is leading the distribution and awareness efforts in China, collaborating with health insurance companies and online health platforms.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 7:12 am

COIN

USDCUSD

Coinbase Global Inc. (NASDAQ:COIN) and Stripe have announced a strategic partnership to enhance cryptocurrency payment solutions. Stripe will integrate Coinbase's Layer 2 network, Base, into its crypto payout products, while Coinbase will incorporate Stripe as a payment method. This collaboration aims to streamline crypto transactions and expand the use of stablecoin USD Coin (USDC).

Portfolio Pulse from Aniket Verma

June 28, 2024 | 3:57 am

CHWY

DJT

NKE

PLTR

TSLA

Major U.S. stock indices closed positively on Thursday. Key stocks on investors' radars included Trump Media & Technology Group, Palantir Technologies, Nike, Chewy, and Tesla. Trump Media shares declined, Palantir rose due to a strategic partnership, Nike saw a slight increase despite a revenue drop, Chewy declined slightly, and Tesla rose following optimistic comments from Elon Musk.

Portfolio Pulse from Benzinga Neuro

June 28, 2024 | 3:01 am